Genosco Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Genosco is a clinical-stage biotechnology company focused on discovering and developing novel small-molecule therapeutics for conditions with unmet medical needs. It is based in Billerica, Massachusetts.

Genosco’s proprietary G-SMART platform guides discovery and optimization by focusing on rare sequences within protein kinases to produce selective small molecules. This approach has yielded a portfolio of several pipelines, developed both independently and in collaboration with partners. Its lead candidate, Lazertinib, is in a global phase 3 trial with Janssen and is also available in Korea for patients with EGFRm+ non-small cell lung cancer. The company maintains ongoing research and discovery programs, supported by an interdisciplinary team with expertise in medicinal chemistry, structural and computational drug discovery design, cell biology, pharmacology, and drug metabolism.

Sign up for free to view info

Company overview Employee directory